Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Asia Pacific Glaucoma Treatment Companies

Glaucoma is a group of eye conditions that can cause optic nerve damage and vision loss. The treatment landscape includes medications, surgical procedures, and medical devices aimed at managing intraocular pressure and preserving vision.

Asia-Pacific Glaucoma Treatment Key Companies

Latest Asia-Pacific Glaucoma Treatment Companies Update

Santen Pharmaceutical Co., Ltd. announces regulatory approval for its Rhokinase inhibitor, Roclatan®, in mainland China, expanding its reach in the largest Glaucoma market in the Asia-Pacific region.

Senju Pharmaceutical Co., Ltd. receives marketing authorization for its prostaglandin analog Travatan® in Indonesia, offering another treatment option for patients in the region.Aeon Vis launches its glaucoma drainage implant, Aquaflow®, in South Korea, providing a minimally invasive alternative for managing severe glaucoma cases.

Glaukos Corporation partners with Alcon Laboratories to distribute its iStent® Inject Trabecular Micro-Bypass System in India and South Korea, leveraging Alcon's established distribution network to reach more patients.

Merck & Co., Inc. collaborates with Bausch + Lomb to develop and commercialize novel therapies for glaucoma in the Asia-Pacific region, combining their expertise and resources to accelerate drug development and market access.

List of Asia-Pacific Glaucoma Treatment Key Companies in the Market

Novartis AG

Pfizer Inc.

Allergan

Merck & Co.

Ocular Therapeutix Inc

pSivida Corp

Icon Bioscience Inc

Amorphex Therapeutics LLC.

Ellex

Quantel

Lumenis

and Lightmed

Asia Pacific Glaucoma Treatment Market Highlights:

Asia Pacific Glaucoma Treatment Market Size

Asia Pacific Glaucoma Treatment Market Trends

Asia Pacific Glaucoma Treatment Market Analysis

Asia Pacific Glaucoma Treatment Market Share

Asia Pacific Glaucoma Treatment Market Highlights:

Asia Pacific Glaucoma Treatment Market Trends

Asia Pacific Glaucoma Treatment Market Analysis

Asia Pacific Glaucoma Treatment Market Share

Asia Pacific Glaucoma Treatment Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.